Subclinical atherosclerosis in relation to hysterectomy status in black women

Stroke

Volumn 29, Issue 4, 1998, Pages 759-764

  Zeigler Johnson, Charnita M ^b   Holmes, Janice L ^a   Lassila, Holly C ^c   Sutton Tyrrell, Kim ^c   Kuller, Lewis H ^c  

^a INDIANA UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE

Author keywords

Atherosclerosis; Blacks; Carotid arteries; Hormones; Ultrasonography, Doppler

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; COLOR ULTRASOUND FLOWMETRY; DISEASE PREDISPOSITION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE ANALYSIS; OVARIECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE;

EID: 0031922197     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.4.759     Document Type: Article

References (36)

1. Kannel WB, Wilson PWF. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155:57-61.
2. Sacco RL, Hauser WA, Mohr JP. Hospitalized stroke in blacks and Hispanics in Northern Manhattan. Stroke. 1991;22:1491-1496.
3. Sprafka JM, Folsom AR, Burke GL, Edlavitch SA. Prevalence of cardiovascular disease risk factors in blacks and whites: The Minnesota Heart Survey. Am J Public Health. 1988;78:1546-1549.
4. Gillum RF. Stroke in blacks. Stroke. 1988; 19:1-9.
5. National Center for Health Statistics. Health United States 1995. Hyattsville, Md: Public Health Service. 1996;127:130.
6. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993;88:1999-2009.
7. The National Heart, Lung, and Blood Institute Growth and Health Study Research Group. Obesity and cardiovascular disease risk factors in black and white girls: The NHLBI Growth and Health Study. Am J Public Health. 1992;82:1613-1620.
8. Healthy People 2000. Washington, DC: Department of Health and Human Services; 1990:93.
9. Summers WE, Watson RL, Wooldridge WH, Langford HG. Hypertension, obesity, and fibromyomata uteri, as a syndrome. Arch Intern Med. 1971;128:750-754.
10. Lackland DT, Keil JE. Epidemiology of hypertension in African-Americans. Semin Nephrol. 1996;16:63-70.
11. Carter-Nolan PL, Adams-Campbell LL, Williams J. Recruitment strategies for black women at risk for noninsulin-dependent diabetes mellitus into exercise protocols: a qualitative assessment. JAMA. 1996; 88:558-562.
12. Otten MW, Teutsch SM, Williamson DF, Marks JS. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA. 1990;263:845-850.
13. Curry CL. Hypertension in black women. Paper presented at Miniconsultation on the Mental and Physical Health Problems of Black Women, sponsored by the Black Women's Community Development Foundation: March 29-30, 1974; Washington, DC.
14. Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine fibromyomata. Nutrition. 1991;7: 251-255.
15. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States. Obstet Gynecol. 1994;83:549-555.
16. Pansini F, Bonaccorsi G, Calisesi M, Campobasso C, Franze GP, Gilli G, Locorotondo G, Mollica G. Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas. 1993;17: 181-190.
17. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
18. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. Ann Intern Med. 1978;89:157-161.
19. Punnonen R, Ikalainen M, Seppala E. Premenopausal hysterectomy and risk of cardiovascular disease. Lancet. 1987;1:1139. Letter.
20. Meilahn EN, Matthews KA, Egeland G, Kelsey SF. Characteristics of women with hysterectomy. Maturitas. 1989;11:319-329.
21. Wing RR, Kuller LH, Bunker C, Matthews K, Caggiula A, Meilahn E, Kelsey S. Obesity, obesity-related behaviors and coronary heart disease risk factors in black and white premenopausal women. Int J Obes. 1989;13:511-519.
22. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Public Health Briefs. 1993;83: 106-108.
23. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance: United States. 1993. MMWR CDC Surveill Summ. 1997;1980:46:1-15.
24. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41:483-490.
25. Kuller LH, Shemanski L, Psaty BM, Borhani NO, Gardin J, Haan MN, O'Leary DH, Savage PJ, Tell GS, Tracy R. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 1995;92: 720-726.
26. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641-646.
27. Sutton-Tyrrell K, Wolfson SK, Thompson T, Kelsey SF. Measurement variability of duplex scan assessment of carotid atherosclerosis. Stroke. 1992;23:215-220.
28. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 1981;139:58-61.
29. Chalmers C. Does hysterectomy in a premenopausal woman affect ovarian function? Med Hypotheses. 1996;46:573-575.
30. Meyers DG. Does iron cause atherosclerosis? Kans Med. Winter 1995: 178-179.
31. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev. 1996;54:73-84.
32. Moss NS, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Am J Pathol. 1975;78:175-190.
33. Edman CD, MacDonald PC. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol. 1978;130:456.
34. Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive cancer. Am J Clin Nutr. 1987;45:283-289.
35. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328: 1069-1075.
36. Bain C, Willett W, Hennekens CH, Rosner B, Belanger C, Speizer FE. Use of postmenopausal hormones and risk of myocardial infarction. Circulation. 1981;64:42-45.